Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily B, polypeptide 6 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | References |
Homo sapiens | melanin-concentrating hormone receptor 1 | Starlite/ChEMBL | References |
Homo sapiens | potassium voltage-gated channel, subfamily H (eag-related), member 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 491 aa | 395 aa | 19.5 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0026 | 0.1789 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0026 | 0.1789 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.3336 | 0.3336 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0026 | 0.1789 | 0.5 |
Trypanosoma brucei | cytochrome P450, putative | 0.0036 | 0.3046 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0036 | 0.3046 | 0.3046 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0026 | 0.1789 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.1789 | 0.3564 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0036 | 0.3046 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0026 | 0.1789 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.3686 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0036 | 0.3046 | 1 |
Brugia malayi | cytochrome P450 | 0.0026 | 0.1789 | 0.1556 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0026 | 0.1789 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.452 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0026 | 0.1789 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0045 | 0.4034 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0036 | 0.3046 | 0.3046 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0045 | 0.4034 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0095 | 1 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.3686 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0026 | 0.1789 | 0.5 |
Schistosoma mansoni | cytochrome P450 | 0.0026 | 0.1789 | 0.3564 |
Loa Loa (eye worm) | cytochrome P450 | 0.0026 | 0.1789 | 0.1789 |
Brugia malayi | Cytochrome P450 family protein | 0.0036 | 0.3046 | 0.2848 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.452 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0026 | 0.1789 | 0.5 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0026 | 0.1789 | 0.4025 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0276 | 0.0276 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0045 | 0.4034 | 0.4034 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0026 | 0.1789 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0036 | 0.3046 | 0.2848 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0026 | 0.1789 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0026 | 0.1789 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0036 | 0.3046 | 0.3046 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0026 | 0.1789 | 0.5 |
Echinococcus multilocularis | 0.0026 | 0.1789 | 0.4025 | |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0026 | 0.1789 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0036 | 0.3046 | 1 |
Mycobacterium leprae | putative cytochrome p450 | 0.0026 | 0.1789 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0045 | 0.4034 | 0.3865 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0036 | 0.3046 | 1 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0026 | 0.1789 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0026 | 0.1789 | 0.1556 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0026 | 0.1789 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 2.8 % | Reduction in body weight in diet induced obese C57BL/6J mouse at 60 mg/kg, po qd | ChEMBL. | 20951036 |
Activity (functional) | = 2.8 % | Antiobesity activity in diet-induced obese mouse assessed as reduction in body weight at 60 mg/kg qd | ChEMBL. | 20952195 |
Activity (functional) | = 2.8 % | Antiobesity activity in diet-induced obese C57BL/6J mouse model assessed as reduction of body weight at 60 mg/kg, po qd for 5 days | ChEMBL. | 20961756 |
Activity (functional) | = 6 % | Antiobesity activity in diet-induced obese mouse assessed as reduction in body weight at 30 mg/kg bid | ChEMBL. | 20952195 |
Activity (functional) | = 6 % | Antiobesity activity in diet-induced obese C57BL/6J mouse model assessed as reduction of body weight at 30 mg/kg, po bid for 5 days | ChEMBL. | 20961756 |
AUC (ADMET) | = 14760 hr.ng/ml | AUC (0 to 6 hrs) in DIO mouse at 30 mg/kg, po | ChEMBL. | 20952195 |
Bmax (binding) | = 13.3 pmol/mg | Binding affinity to MCH-1 receptor | ChEMBL. | 20952195 |
Cp (ADMET) | = 1950 ng/ml | Drug level in DIO mouse plasma at 30 mg/kg, po after 6 hrs | ChEMBL. | 20952195 |
Cp (ADMET) | = 2224 ng/ml | Plasma concentration in mouse at 30 mg/kg after 6 hrs | ChEMBL. | 20961756 |
Drug uptake (ADMET) | = 1485 ng/g | Drug level in mouse brain at 30 mg/kg after 6 hrs | ChEMBL. | 20961756 |
Drug uptake (ADMET) | = 1377 ng/ml | Drug level in DIO mouse brain at 30 mg/kg, po after 6 hrs | ChEMBL. | 20952195 |
IC50 (functional) | = 14 nM | Antagonistic activity at MCH-1 receptor expressed in CHO-K1 cell assessed as inhibition of MCH-induced calcium release | ChEMBL. | 20961756 |
IC50 (binding) | = 2.5 uM | Inhibition of human ERG expressed in HEK cells by mini-patch clamp assay | ChEMBL. | 20961756 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2D6 | ChEMBL. | 20952195 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C19 | ChEMBL. | 20952195 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2B6 | ChEMBL. | 20952195 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP1A2 | ChEMBL. | 20952195 |
IC50 (ADMET) | = 10 uM | Inhibition of CYP3A4 | ChEMBL. | 20952195 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C9 | ChEMBL. | 20952195 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C9 | ChEMBL. | 20961756 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2D6 | ChEMBL. | 20961756 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C19 | ChEMBL. | 20961756 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP1A2 | ChEMBL. | 20961756 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2B6 | ChEMBL. | 20961756 |
IC50 (ADMET) | = 10 uM | Inhibition of CYP3A4 | ChEMBL. | 20961756 |
Kd (binding) | = 1.42 nM | Binding affinity to MCH-1 receptor | ChEMBL. | 20952195 |
Ki (binding) | = 2.6 nM | Displacement of [3H]GW803430 from MCH-1 receptor expressed in CHO-K1 cells | ChEMBL. | 20951036 |
Ki (binding) | = 2.6 nM | Displacement of [3H]4-(benzyloxy)-1-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-indazol-5-yl)pyridin-2(1H)-one from MCH-1 receptor expressed in CHO-K1 cells | ChEMBL. | 20952195 |
Ki (binding) | = 2.6 nM | Displacement of [3H]4-(benzyloxy)-1-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-indazol-5-yl)pyridin-2(1H)-one from MCH-1 receptor expressed in CHO-K1 cells | ChEMBL. | 20961756 |
PPB (ADMET) | = 91.4 % | Plasma protein binding in DIO mouse at 30 mg/kg, po | ChEMBL. | 20952195 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.